HealthEquity, Inc. (HQY) — Analyst outlook / Analyst consensus target is. Based on 27 analyst ratings, the consensus is bullish — 1 Strong Buy, 24 Buy, 1 Hold, 1 Sell.
The consensus price target is $107.67 (low: $85.00, high: $125.00), representing an upside of 32.3% from the current price $81.36.
Analysts estimate Earnings Per Share (EPS) of $1.22 and revenue of $1.10B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.65 vs est $1.22 (missed -46.9%). 2025: actual $1.11 vs est $3.15 (missed -64.8%). 2026: actual $2.50 vs est $3.96 (missed -36.8%). Analyst accuracy: 0%.
HQY Stock — 12-Month Price Forecast
$107.67
▲ +32.34% Upside
Average Price Target
Based on 27 Wall Street analysts offering 12-month price targets for HealthEquity, Inc., the average price target is $107.67, with a high forecast of $125.00, and a low forecast of $85.00.
The average price target represents a +32.34% change from the last price of $81.36.
Highest Price Target
$125.00
Average Price Target
$107.67
Lowest Price Target
$85.00
HQY Analyst Ratings
Buy
Based on 27 analysts giving stock ratings to HealthEquity, Inc. in the past 3 months
EPS Estimates — HQY
0%
Analyst Accuracy
Inaccurate
3 years compared
Actual vs Estimate
2024
Actual $0.65
vs Est $1.22
▼ 88.3% off
2025
Actual $1.11
vs Est $3.15
▼ 184.1% off
2026
Actual $2.50
vs Est $3.96
▼ 58.2% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving.
Revenue Estimates — HQY
96%
Analyst Accuracy
Accurate
3 years compared
Actual vs Estimate
2024
Actual $1.000B
vs Est $1.099B
▼ 10.0% off
2025
Actual $1.200B
vs Est $1.194B
▲ 0.5% off
2026
Actual $1.313B
vs Est $1.312B
▲ 0.1% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
